Immutep Limited (ASX:IMM)
Australia · Delayed Price · Currency is AUD 0.0600
+0.0010 (1.69%)
May 8, 2026, 4:10 PM AEST
Immutep Market Cap
Immutep has a market cap or net worth of 88.42 million as of May 8, 2026. Its market cap has decreased by -75.29% in one year.
Market Cap
88.42M
Enterprise Value
-9.50M
Revenue
7.92M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.06
Market Cap Chart
Since August 29, 1996, Immutep's market cap has increased from 3.66M to 88.42M, an increase of 2,313.98%. That is a compound annual growth rate of 11.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 88.42M | -85.54% |
| Dec 31, 2025 | 611.59M | 15.11% |
| Dec 31, 2024 | 531.29M | 29.54% |
| Dec 29, 2023 | 410.15M | 69.62% |
| Dec 30, 2022 | 241.81M | -42.22% |
| Dec 31, 2021 | 418.52M | 55.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dimerix | 129.09M |
| Alterity Therapeutics | 108.75M |
| Island Pharmaceuticals | 104.31M |
| Arovella Therapeutics | 90.66M |
| Paradigm Biopharmaceuticals | 89.33M |
| Cynata Therapeutics | 79.55M |
| LTR Pharma | 76.35M |
| Botanix Pharmaceuticals | 68.01M |